Closing the knowledge gap on cardiovascular disease in type 2 diabetes: the EMPA-REG OUTCOME trial and beyond

por Oral, Elif A
Publicado 2016

SAT155 Insulin Receptor Autoantibody Syndrome (Iras): A Rare Occurrence In Lymphoproliferative Disease

por Santos, Claudia Villatoro, Oral, Elif A
Publicado 2023

Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People

por Özen, Samim, Akıncı, Barış, Oral, Elif A.
Publicado 2020

Abnormal Non Esterified Fatty Acid Suppression After a Mixed Meal Test in Patients With Partial Lipodystrophy

por de Freitas, Maria Cristina Foss, Akinci, Baris, Oral, Elif A
Publicado 2021

Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program

por Ajluni, Nevin, Dar, Moahad, Xu, John, Neidert, Adam H, Oral, Elif A
Publicado 2016

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

por Chiquette, Elaine, Oral, Elif A, Garg, Abhimanyu, Araújo-Vilar, David, Dhankhar, Praveen
Publicado 2017

Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome

por Walden, Patrick, Jiang, Qingmei, Jackson, Elizabeth A, Oral, Elif A, Weintraub, Martha S, Rubenfire, Melvyn
Publicado 2016

Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy

por de Freitas, Maria Cristina Foss, Akinci, Baris, Neidert, Adam, Hench, Rita, Oral, Elif A
Publicado 2021

SAT-617 Potential Utility of the Mixed Meal Test for Differential Diagnosis of Partial Lipodystrophy from Common Type 2 Diabetes and Truncal Obesity

por Guraya, Armaan, de Freitas, Maria Cristina Foss, Akinci, Baris, Eldin, Abdelwahab Jalal, Oral, Elif A
Publicado 2020

SUN-600 Presence of LMNA p.R582H Pathogenic Variant in Homozygous State Demonstrates Gene Dosage Effect on the Severity of Fat Loss in Lipodystrophy

por Soyaltin, Utku Erdem, Simsir, Ilgin Yildirim, Akinci, Baris, Altay, Canan, Adiyaman, Suleyman Cem, Oral, Elif A
Publicado 2020

FRI028 Multiple Symmetric Lipomatosis As A Model For Understanding The Importance Of Mitochondria Function On Adipose Tissue Biology

por Foss de Freitas, Maria Cristina, Gilio, Donatella, DillGomes, Anabela, Grissi, Fatiha, Imam, Salman, Oral, Elif A
Publicado 2023

2287 ECG and echo characteristics in familial partial lipodystrophy: The impact of Lamin A variants

por Eldin, Abdelwahab J., Meral, Rasimcan, Neidert, Adam H., Rus, Diana, Hench, Rita, Oral, Hakan, Oral, Elif A.
Publicado 2018

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin

por Esfandiari, Nazanene H., Rubenfire, Melvyn, Neidert, Adam H., Hench, Rita, Eldin, Abdelwahab Jalal, Meral, Rasimcan, Oral, Elif A.
Publicado 2019

SAT-574 Whole Exome Sequencing Identifies Several Variants Associated with Immune Deficiency, Inflammasomopathy and Non-Ischemic Dilated Cardiomyopathy in a Complex Case of Acquire...

por Brandao, Marjorie Azevedo Jales, de Freitas, Maria Cristina Foss, Akinci, Baris, Hannibal, Mark, Walkovich, Kelly, Oral, Elif A
Publicado 2020

SAT-622 Heterogeneity of Familial Partial Lipodystrophy Type 2 from a Genotype-Phenotype Perspective

por de Freitas, Maria Cristina Foss, Eldin, Abdelwahab Jalal, Akinci, Baris, Corsa, Callie, MacDougald, Ormond A, Oral, Elif A
Publicado 2020

Body Composition And Bone Mineral Differences According to Lamin A (LMNA) Genotype in Familial Partial Lipodystrophy Type 2

por de Freitas, Maria Cristina Foss, Akinci, Baris, Corsa, Callie, Rothberg, Amy E, MacDougald, Ormond A, Oral, Elif A
Publicado 2021

Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study

por Foss-Freitas, Maria C., Akinci, Baris, Neidert, Adam, Bartlett, Victoria J., Hurh, Eunju, Karwatowska-Prokopczuk, Ewa, Oral, Elif A.
Publicado 2021

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy

por Mendell, Jeanne, Wang, Yuhuan, Olenchock, Ben A, Podgrabinska, Simona, Pagovich, Odelya E, Oral, Elif A, Brown, Rebecca J, Davis, John
Publicado 2023

SAT080 Partnering With Medical Genetics To Provide Molecular Diagnosis In Atypical Diabetes

por Foss de Freitas, Maria Cristina, Chase, Colby, Henry, Marie-Louise, Neidert, Adam, Narla, Goutham, Uhlmann, Wendy, Lee, Kristen, Oral, Elif A
Publicado 2023

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461

por Akinci, Baris, de Freitas, Maria Cristina Foss, Baker, Mark, Hench, Rita, Neidert, Adam, Boutros, Sabine, Akinci, Efe Yagiz, Oral, Elif A
Publicado 2020